AAPL315.91-4.06 (-1.27%) ▼|ABBV250.62-5.84 (-2.28%) ▼|ABT105.72-2.61 (-2.41%) ▼|ACN178.68-8.05 (-4.31%) ▼|ADBE257.90-8.61 (-3.23%) ▼|AMAT470.10+15.39 (+3.38%) ▲|AMD508.05+30.48 (+6.38%) ▲|AMGN395.81-41.42 (-9.47%) ▼|AMT177.45+1.60 (+0.91%) ▲|AMZN257.21-1.30 (-0.50%) ▼|AVGO371.22+13.32 (+3.72%) ▲|AXP327.57+1.41 (+0.43%) ▲|BA215.19+2.94 (+1.39%) ▲|BAC62.65-0.04 (-0.06%) ▼|BKNG182.48-10.81 (-5.59%) ▼|BLK1,106.10-10.46 (-0.94%) ▼|BMY65.01-1.81 (-2.71%) ▼|BNY164.30-0.55 (-0.33%) ▼|BRK-B504.34-1.69 (-0.33%) ▼|C137.64-0.09 (-0.06%) ▼|CAT828.40+14.46 (+1.78%) ▲|CL88.20-0.57 (-0.64%) ▼|CMCSA26.15-0.35 (-1.30%) ▼|COF216.29-3.32 (-1.51%) ▼|COP135.48+1.22 (+0.91%) ▲|COST907.74-8.01 (-0.87%) ▼|CRM250.47-8.77 (-3.38%) ▼|CSCO109.38+0.18 (+0.16%) ▲|CVS95.76-0.98 (-1.02%) ▼|CVX211.10+2.50 (+1.20%) ▲|DE683.73-9.80 (-1.41%) ▼|DHR205.78-1.88 (-0.91%) ▼|DIS104.56-0.75 (-0.71%) ▼|DUK121.17+0.95 (+0.79%) ▲|EMR153.67+0.85 (+0.56%) ▲|FDX318.85-3.67 (-1.14%) ▼|GD356.23-3.17 (-0.88%) ▼|GE338.87+1.75 (+0.52%) ▲|GEV961.23+19.28 (+2.05%) ▲|GILD146.16-4.84 (-3.20%) ▼|GM85.74-2.02 (-2.30%) ▼|GOOG335.45+0.14 (+0.04%) ▲|GOOGL338.53+0.07 (+0.02%) ▲|GS1,039.75+1.14 (+0.11%) ▲|HD317.30-3.75 (-1.17%) ▼|HON208.59-1.02 (-0.49%) ▼|IBM232.56-2.33 (-0.99%) ▼|INTC104.17+8.37 (+8.74%) ▲|INTU314.87-17.83 (-5.36%) ▼|ISRG350.35-16.35 (-4.46%) ▼|JNJ267.95-7.28 (-2.65%) ▼|JPM356.50-2.15 (-0.60%) ▼|KO87.91-0.16 (-0.18%) ▼|LIN470.26-7.31 (-1.53%) ▼|LLY1,119.32-30.04 (-2.61%) ▼|LMT540.95+15.67 (+2.98%) ▲|LOW202.44-2.02 (-0.99%) ▼|LRCX321.09+13.44 (+4.37%) ▲|MA568.31-10.91 (-1.88%) ▼|MCD255.65-0.04 (-0.02%) ▼|MDLZ60.97-0.31 (-0.51%) ▼|MDT91.82-2.35 (-2.50%) ▼|META616.72-0.05 (-0.01%) ▼|MMM166.26-2.30 (-1.36%) ▼|MO67.93-0.95 (-1.38%) ▼|MRK148.31-2.02 (-1.34%) ▼|MS218.05+0.33 (+0.15%) ▲|MSFT492.98-6.72 (-1.34%) ▼|MU1,019.25+2.66 (+0.26%) ▲|NEE84.09+0.66 (+0.79%) ▲|NFLX76.62-1.63 (-2.09%) ▼|NKE38.17-0.24 (-0.61%) ▼|NOW135.35-5.91 (-4.18%) ▼|NVDA226.66-3.70 (-1.61%) ▼|ORCL164.53+5.75 (+3.62%) ▲|PEP137.98+0.35 (+0.25%) ▲|PFE27.87-0.58 (-2.04%) ▼|PG144.69-1.75 (-1.20%) ▼|PLTR171.34-2.99 (-1.72%) ▼|PM184.68+2.15 (+1.18%) ▲|QCOM176.10+7.36 (+4.36%) ▲|RTX198.64-2.16 (-1.07%) ▼|SBUX102.87-1.60 (-1.53%) ▼|SCHW108.08-1.22 (-1.11%) ▼|SO89.01+0.90 (+1.02%) ▲|SPG209.60+0.16 (+0.08%) ▲|T25.72+0.04 (+0.17%) ▲|TMO600.83-12.95 (-2.11%) ▼|TMUS180.58-0.94 (-0.52%) ▼|TSLA366.87+12.79 (+3.61%) ▲|TXN259.90+1.46 (+0.56%) ▲|UBER73.45-2.32 (-3.06%) ▼|UNH395.99-1.15 (-0.29%) ▼|UNP289.92+0.30 (+0.10%) ▲|UPS101.22-1.07 (-1.05%) ▼|USB62.86-0.52 (-0.81%) ▼|V368.13-6.94 (-1.85%) ▼|VZ50.32+0.18 (+0.35%) ▲|WFC88.76-1.22 (-1.35%) ▼|WMT106.06-1.08 (-1.01%) ▼|XOM159.62+0.15 (+0.09%) ▲|AAPL315.91-4.06 (-1.27%) ▼|ABBV250.62-5.84 (-2.28%) ▼|ABT105.72-2.61 (-2.41%) ▼|ACN178.68-8.05 (-4.31%) ▼|ADBE257.90-8.61 (-3.23%) ▼|AMAT470.10+15.39 (+3.38%) ▲|AMD508.05+30.48 (+6.38%) ▲|AMGN395.81-41.42 (-9.47%) ▼|AMT177.45+1.60 (+0.91%) ▲|AMZN257.21-1.30 (-0.50%) ▼|AVGO371.22+13.32 (+3.72%) ▲|AXP327.57+1.41 (+0.43%) ▲|BA215.19+2.94 (+1.39%) ▲|BAC62.65-0.04 (-0.06%) ▼|BKNG182.48-10.81 (-5.59%) ▼|BLK1,106.10-10.46 (-0.94%) ▼|BMY65.01-1.81 (-2.71%) ▼|BNY164.30-0.55 (-0.33%) ▼|BRK-B504.34-1.69 (-0.33%) ▼|C137.64-0.09 (-0.06%) ▼|CAT828.40+14.46 (+1.78%) ▲|CL88.20-0.57 (-0.64%) ▼|CMCSA26.15-0.35 (-1.30%) ▼|COF216.29-3.32 (-1.51%) ▼|COP135.48+1.22 (+0.91%) ▲|COST907.74-8.01 (-0.87%) ▼|CRM250.47-8.77 (-3.38%) ▼|CSCO109.38+0.18 (+0.16%) ▲|CVS95.76-0.98 (-1.02%) ▼|CVX211.10+2.50 (+1.20%) ▲|DE683.73-9.80 (-1.41%) ▼|DHR205.78-1.88 (-0.91%) ▼|DIS104.56-0.75 (-0.71%) ▼|DUK121.17+0.95 (+0.79%) ▲|EMR153.67+0.85 (+0.56%) ▲|FDX318.85-3.67 (-1.14%) ▼|GD356.23-3.17 (-0.88%) ▼|GE338.87+1.75 (+0.52%) ▲|GEV961.23+19.28 (+2.05%) ▲|GILD146.16-4.84 (-3.20%) ▼|GM85.74-2.02 (-2.30%) ▼|GOOG335.45+0.14 (+0.04%) ▲|GOOGL338.53+0.07 (+0.02%) ▲|GS1,039.75+1.14 (+0.11%) ▲|HD317.30-3.75 (-1.17%) ▼|HON208.59-1.02 (-0.49%) ▼|IBM232.56-2.33 (-0.99%) ▼|INTC104.17+8.37 (+8.74%) ▲|INTU314.87-17.83 (-5.36%) ▼|ISRG350.35-16.35 (-4.46%) ▼|JNJ267.95-7.28 (-2.65%) ▼|JPM356.50-2.15 (-0.60%) ▼|KO87.91-0.16 (-0.18%) ▼|LIN470.26-7.31 (-1.53%) ▼|LLY1,119.32-30.04 (-2.61%) ▼|LMT540.95+15.67 (+2.98%) ▲|LOW202.44-2.02 (-0.99%) ▼|LRCX321.09+13.44 (+4.37%) ▲|MA568.31-10.91 (-1.88%) ▼|MCD255.65-0.04 (-0.02%) ▼|MDLZ60.97-0.31 (-0.51%) ▼|MDT91.82-2.35 (-2.50%) ▼|META616.72-0.05 (-0.01%) ▼|MMM166.26-2.30 (-1.36%) ▼|MO67.93-0.95 (-1.38%) ▼|MRK148.31-2.02 (-1.34%) ▼|MS218.05+0.33 (+0.15%) ▲|MSFT492.98-6.72 (-1.34%) ▼|MU1,019.25+2.66 (+0.26%) ▲|NEE84.09+0.66 (+0.79%) ▲|NFLX76.62-1.63 (-2.09%) ▼|NKE38.17-0.24 (-0.61%) ▼|NOW135.35-5.91 (-4.18%) ▼|NVDA226.66-3.70 (-1.61%) ▼|ORCL164.53+5.75 (+3.62%) ▲|PEP137.98+0.35 (+0.25%) ▲|PFE27.87-0.58 (-2.04%) ▼|PG144.69-1.75 (-1.20%) ▼|PLTR171.34-2.99 (-1.72%) ▼|PM184.68+2.15 (+1.18%) ▲|QCOM176.10+7.36 (+4.36%) ▲|RTX198.64-2.16 (-1.07%) ▼|SBUX102.87-1.60 (-1.53%) ▼|SCHW108.08-1.22 (-1.11%) ▼|SO89.01+0.90 (+1.02%) ▲|SPG209.60+0.16 (+0.08%) ▲|T25.72+0.04 (+0.17%) ▲|TMO600.83-12.95 (-2.11%) ▼|TMUS180.58-0.94 (-0.52%) ▼|TSLA366.87+12.79 (+3.61%) ▲|TXN259.90+1.46 (+0.56%) ▲|UBER73.45-2.32 (-3.06%) ▼|UNH395.99-1.15 (-0.29%) ▼|UNP289.92+0.30 (+0.10%) ▲|UPS101.22-1.07 (-1.05%) ▼|USB62.86-0.52 (-0.81%) ▼|V368.13-6.94 (-1.85%) ▼|VZ50.32+0.18 (+0.35%) ▲|WFC88.76-1.22 (-1.35%) ▼|WMT106.06-1.08 (-1.01%) ▼|XOM159.62+0.15 (+0.09%) ▲|
25.3 C
New York
Tuesday, September 8, 2026

Tag: address

newssourceFORcompanyinformationcontent1releasesmarket

HorseWood & HorseBoost [Exclusive Report 2026] The Horse Gelatin Trick Male Enhancement Or Why Talking About Natural Vitality Supplement Horse Boost?

Discover the truth behind HorseWood & HorseBoost in this 2026 exclusive report. Learn how the Horse Gelatin Trick works, what ingredients are included, and whether this natural vitality supplement can support male performance, stamina, and confidence. 
Discover the truth behind HorseWood & HorseBoost in this 2026 exclusive report. Learn how the Horse Gelatin Trick works, what ingredients are included, and whether this natural vitality supplement can support male performance, stamina, and confidence.

TAIWAN DESIGN POWER Debuts at Busan Design Festival, Showcasing Taiwan’s Design Innovation and Creative Value

The "TAIWAN DESIGN POWER" Taiwan Pavilion, showcased at the Busan Design Festival in South Korea, brings together 25 design projects and 20 industry representatives, demonstrating...

ICE Box Claims Evaluated: Personal Document Storage System for Organization & Secure Protection in Case of Emergencies

ICE Box organizes vital records, estate planning documents, and emergency files in one fireproof box with a 32GB USB stick and expert-developed checklist.

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism

COPENHAGEN, Denmark, June 13, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced Week 182 data from its completed Phase 3 PaTHway Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) demonstrated sustained efficacy and safety in adults with hypoparathyroidism. Over the three-and-a-half-year duration of the trial, TransCon PTH replicated the systemic actions of endogenous PTH, with a balanced, beneficial impact on the main target organ systems – CNS, kidney, small intestine, and bone – as demonstrated by improved quality of life and normalized and stable urine calcium, serum calcium, serum phosphate, and bone mineral density. These benefits were sustained while enabling independence from conventional therapy with active vitamin D and calcium.

HeroMD 4-MAX Claims Evaluated: Why Men Searching “Most Effective 4-in-1 Erectile Dysfunction Formula” Are Comparing SURGE, PRIME and The HERO System Explained

HeroMD 4-MAX scam or legit? Compounded 4-in-1 sublingual ED formula with 10-min onset and 36-hr window reviewed.

Don’t Pay Full Price for Power: WattCycle’s Prime Day Event Drops Up to 70% Off LiFePO4 Batteries Starting June 15

WattCycle’s June 15-30 sale offers up to 70% off LiFePO4 batteries. Enjoy new arrivals, double points, giveaways & 8% off code: WattCyclePrimeDay.

FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch

FREELANDER 8 made its first public appearance at the Abu Dhabi Investment Forum held at The Peninsula Shanghai on June 11, 2026.

 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat mass with preservation of lean mass, and improvements in hyperphagia and anxiety measures --   

-- Positive results reinforce rationale for Phase 3 development of MC4R agonism in PWS --

New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

BEERSE, BELGIUM, June 13, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced results from the investigational Phase 3 MonumenTAL-3 study.1 The results showed that TALVEY® (talquetamab), a GPRC5D bispecific antibody, in combination with daratumumab with or without pomalidomide demonstrated significant reduction in the risk of disease progression or death of up to 72.0%, and clinically meaningful reduction of up to 53.0% in the risk of death, compared to the standard regimen of daratumumab, pomalidomide, and dexamethasone (DPd) in patients with relapsed or refractory multiple myeloma (RRMM).1 Results showed a progression-free survival (PFS) rate of up to 81.3% versus standard of care (51.2%) and an overall survival (OS) rate of up to 89.2% versus standard of care (79.1%) at 24 months.1  

FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch

FREELANDER 8 made its first public appearance at the Abu Dhabi Investment Forum held at The Peninsula Shanghai on June 11, 2026.

Breakthrough T1D Celebrates Approval of Tzield for use in Stage 3 Type 1 Diabetes in the US

NEW YORK, June 12, 2026 /PRNewswire/ -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today's decision from the...

Monroe University Celebrates the Class of 2026 at Commencement

New York Assemblymembers Karines Reyes andChantel Jackson Deliver Commencement AddressesBRONX, N.Y., June 12, 2026 /PRNewswire/ -- Monroe University, a national leader in educating first-generation...

HASA Inc. Acquires Swimming Pool Chemicals Manufacturer Bio-Dex Laboratories, Inc.

VALENCIA, Calif., June 12, 2026 /PRNewswire/ -- HASA Inc. (www.hasa.com), a leading producer and distributor of high-quality water treatment solutions, today announced the acquisition of Bio–Dex Laboratories,...

HorseWood Claims Evaluated: The Horse Gelatin Trick for Natural Male Enhancement Support

Horsewood supplement evaluated: 7-herb botanical male vitality formula, NCCIH research context, and 60-day money-back guarantee.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAddress

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers